On the recordMarch 1, 2017
I am concerned that this executive order could in fact make it more difficult to implement these agreements and respond to the applications.
Source
congress.govEditor's note · Context
Butterfield expresses concern over an executive order impacting FDA agreements and responsiveness.
Share & report
More from G. K. Butterfield
Jan 13, 2022
Mr. Speaker, I yield 1 minute to the gentleman from New York (Mr. Jeffries), the chairman of the House Democratic Caucus.
Jan 13, 2022
Mr. Speaker, I have a motion at the desk. The SPEAKER pro tempore. The Clerk will designate the motion. The text of the motion is as follows: Mr. Butterfield of North Carolina moves that the House concur in the Senate amendment to H.R…
Apr 10, 2022
Section 5 has been very meaningful and has meant a lot to the political progress the minority groups have made across the country.
Jan 13, 2022
Madam Speaker, may I inquire about how much time each side has remaining. The SPEAKER pro tempore (Ms. Clark of Massachusetts). The gentleman from North Carolina has 6\1/2\ minutes remaining. The gentleman from Illinois has 2\1/4\ minutes…
Other voices in this conversation
